This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Cenix Bioscience Gmbh. Active years: 2009-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2010
Title: Andrew Walsh: Innovator in Cell Cycle Research
Introduction
Andrew Walsh is a prominent inventor based in Dresden, Germany. He has made significant contributions to the field of cell cycle research, particularly in the diagnosis and treatment of proliferative diseases. With a total of 2 patents, his work has the potential to impact medical science and therapeutic approaches.
Latest Patents
Walsh's latest patents focus on the use of eukaryotic genes that affect cell cycle control and spindle formation during cell division. The first patent discusses the significant functional role of several genes and their corresponding gene products in cell cycle progression. This invention highlights the identification of functional orthologs of these genes through RNA-mediated interference (RNAi). It also emphasizes the development of anti-proliferative agents and their application in screening assays for diagnosis and treatment of proliferative diseases. The second patent similarly addresses the role of genes in spindle formation and microtubule function, again utilizing RNAi for identification and isolation of functional orthologs. This invention also aims to develop small interfering RNAs for treating proliferative diseases.
Career Highlights
Andrew Walsh is currently associated with Cenix Bioscience GmbH, where he continues to advance his research in cell biology. His work is characterized by a strong focus on the molecular mechanisms underlying cell division and their implications for disease treatment.
Collaborations
Walsh has collaborated with notable scientists in his field, including Christophe Echeverri and Anthony A Hyman. These collaborations have further enriched his research and contributed to the advancement of knowledge in cell cycle control.
Conclusion
Andrew Walsh's innovative work in the realm of cell cycle research and his patents on eukaryotic genes demonstrate his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the diagnosis and treatment of proliferative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile